Sathyan A, Mohanapriya M, Madhanraja R, et al. A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab. J. Drug Delivery Ther. 2025;15(2):149-155. doi:10.22270/jddt.v15i2.7012